Kazia Therapeutics Total Assets Growth & History (KZIA)
Kazia Therapeutics's total assets was $6.1M for fiscal 2025.
View full Kazia Therapeutics company overviewKazia Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $6.1M | −$15.5M | −71.93% |
| 2024 | 2024-06-30 | $21.6M | −$6.5M | −23.14% |
| 2023 | 2023-06-30 | $28.1M | −$7.8M | −21.75% |
| 2022 | 2022-06-30 | $35.9M | −$22.2M | −38.22% |
| 2021 | 2021-06-30 | $58.1M | $35.0M | +151.87% |
| 2020 | 2020-06-30 | $23.1M | $1.9M | +8.91% |
| 2019 | 2019-06-30 | $21.2M | −$7.0M | −24.84% |
| 2018 | 2018-06-30 | $28.2M | −$7.7M | −21.54% |
| 2017 | 2017-06-30 | $35.9M | — | — |
Kazia Therapeutics quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | $71.1M | $53.2M | +297.01% |
| Q4 2025 | 2025-06-30 | $6.1M | −$15.5M | −71.93% |
| Q2 2025 | 2024-12-31 | $17.9M | −$6.5M | −26.54% |
| Q4 2024 | 2024-06-30 | $21.6M | −$6.5M | −23.14% |
| Q2 2024 | 2023-12-31 | $24.4M | −$3.5M | −12.40% |
| Q4 2023 | 2023-06-30 | $28.1M | −$7.8M | −21.75% |
| Q2 2023 | 2022-12-31 | $27.8M | — | — |
| Q4 2022 | 2022-06-30 | $35.9M | −$22.2M | −38.22% |
| Q4 2021 | 2021-06-30 | $58.1M | $35.0M | +151.87% |
| Q4 2020 | 2020-06-30 | $23.1M | $1.9M | +8.91% |
| Q4 2019 | 2019-06-30 | $21.2M | −$7.0M | −24.84% |
| Q4 2018 | 2018-06-30 | $28.2M | −$7.7M | −21.54% |
| Q4 2017 | 2017-06-30 | $35.9M | — | — |
Kazia Therapeutics total assets trends
Over the last five fiscal years, Kazia Therapeutics's total assets decreased from $23.1M to $6.1M, a change of −$17.0M. The latest reported quarter, Q2 2026, shows $71.1M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kazia Therapeutics source filings ↗